About Mylan

Placeholder image



Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands and with operational headquarters in Hatfield Hertfordshire in the United Kingdom. In 2007 Mylan acquired a controlling interest in India-based Matrix Laboratories Limited a top producer of active pharmaceutical ingredients for generic drugs and the generics business of Germany-based Merck KGaA. Through these acquisitions Mylan has grown from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world. Mylan now has approximately 30 000 employees more than 1 000 separate products and serves customers in more than 150 countries and territories. Mylan has a global manufacturing output of more than 45 billion doses.